0001181431-13-023457.txt : 20130425
0001181431-13-023457.hdr.sgml : 20130425
20130425165609
ACCESSION NUMBER: 0001181431-13-023457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130423
FILED AS OF DATE: 20130425
DATE AS OF CHANGE: 20130425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH GROWTH N V
CENTRAL INDEX KEY: 0001259869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35726
FILM NUMBER: 13783564
MAIL ADDRESS:
STREET 1: DE RUYTERKADE 62 WILLEMSTAD
CITY: CURACO
STATE: P8
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Radius Health, Inc.
CENTRAL INDEX KEY: 0001428522
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 800145732
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 425 9225
MAIL ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MPM ACQUISITION CORP
DATE OF NAME CHANGE: 20080228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35726
FILM NUMBER: 13783563
BUSINESS ADDRESS:
STREET 1: VODERGASSE 3
STREET 2: SWITZERLAND
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: CH-8300
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: VODERGASSE 3
STREET 2: SWITZERLAND
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: CH-8300
4
1
rrd377636.xml
FORM 4
X0306
4
2013-04-23
0
0001428522
Radius Health, Inc.
NONE
0001259869
BIOTECH GROWTH N V
SNIPWEG 26
CURACAO
00000
0
0
1
0
0000924223
BB BIOTECH AG
VORDERGASSE 3
SCHAFFHAUSEN
V8
8200
SWITZERLAND
0
0
1
0
Series B Convertible Preferred Stock
2013-04-23
4
P
0
97688
61.42
A
2013-04-23
Common Stock
976880
97688
D
Common Stock Warrant
6.142
2013-04-23
4
P
0
244220
A
2013-04-23
2018-04-23
Common Stock
244220
244220
D
Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.
Each share of the Series B Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion rate of 10 shares of Common Stock for every 1 share of Series B Convertible Preferred Stock.
Payment of an aggregate purchase price equal to the product of (i) $61.42 multiplied by (ii) the total number of reported shares of Series B Convertible Preferred Stock entitled the purchaser to receive the reported shares of Series B Convertible Preferred Stock as well as the reported Warrant exercisable for shares of Common Stock.
/s/ Pascal Schmucki Signatory Authority for Biotech Growth N.V. and BB Biotech AG
2013-04-25